A conserved population of genetically defined striatal neurons gates opioid reward
Authors:
- Olivia R. DrakeODOlivia R. Drake
- Caroline M. FioreCFCaroline M. Fiore
- Emily T. JorgensenEJEmily T. Jorgensen
- Catherine E. NewmanCNCatherine E. Newman
- Luke A. PotterLPLuke A. Potter
- Austyn TrullATAustyn Trull
- Lara IanovLILara Ianov
- Jamie PetersJPJamie Peters
- Jasper A. HeinsbroekJHJasper A. Heinsbroek
- Jeremy J. DayJDJeremy J. Day
Preprint
Abstract
Summary: A longstanding paradox in striatal circuit architecture is that opioid reward depends on μ-opioid receptors (µORs) in nucleus accumbens medium spiny neurons (MSNs), yet µOR function is not explained by the canonical D1/direct and D2/indirect pathway organization. Here, we identify a rare MSN population marked by Chst9 that exhibits exceptionally high expression of the µOR and is conserved across species. Notably, Chst9-MSNs comprise a specialized indirect pathway striatal neuron subtype that is molecularly and spatially distinct from canonical striatal populations. Opioids robustly silence Chst9-MSNs, and selective deletion of Oprm1 from this population abolishes fentanyl-conditioned place preference. These findings establish Chst9-MSNs as a critical substrate for opioid reward and define a new cellular framework for therapies targeting opioid use disorder.Keywords
Funding Information
- Heersink School of Medicine, University of Alabama at Birmingham (Multi-PI award)
This publication has 110 references indexed in Scilit:
- Engaging endogenous opioid circuits in pain affective processesJournal of Neuroscience Research, 2020
- Association of OPRM1 Functional Coding Variant With Opioid Use DisorderJAMA Psychiatry, 2020
- Reward Circuitry in AddictionNeurotherapeutics, 2017
- A mu–delta opioid receptor brain atlas reveals neuronal co-occurrence in subcortical networksBrain Structure and Function, 2014
- Molecular Assays for Characterization of Alternatively Spliced Isoforms of the Mu Opioid Receptor (MOR)2010
- Addiction molecular genetics: 639,401 SNP whole genome association identifies many “cell adhesion” genesAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2006
- Anatomical and pharmacological specificity of the rewarding effect elicited by microinjections of morphine into the nucleus accumbens of micePsychopharmacology, 2000
- Opiate agonists microinjected into the nucleus accumbens enhance sucrose drinking in ratsPsychopharmacology, 1997
- D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAS in distinct neuronal populations of the dorsal and ventral striatumJournal of Comparative Neurology, 1995
- Reinforcing effects of morphine in the nucleus accumbensBrain Research, 1982